Cite

HARVARD Citation

    Ruff, M. et al. (2019). Neuro-Oncology Clinical Debate: PCV or temozolomide in combination with radiation for newly diagnosed high-grade oligodendroglioma. Neuro-oncology practice. 6 (1), pp. 17-21. [Online]. 
  
Back to record